กรุงเทพฯ--17 ก.ย.--ABM Connect
- Overall Thailand NCD Patients: 10.5 million
- NCD patients Upjohn Thailand can support with our existing portfolios: 6.2 million
- Upjohn Thailand Mission 2020: Reach 1.5 million patients
- Upjohn Thailand Mission 2025: Reach 2 million patients
Upjohn Thailand announced its commitment and integrated strategy to improve patient health and relieve the burden of non-communicable diseases (NCDs) with trusted, quality medicines for every patient, everywhere. As Upjohn expands its capability in treating and preventing NCDs in Thailand, Upjohn (Thailand) Limited was established to promote good health for all Thais with targeted coverage of more than 1.5 million patients in 2020 and 2 million patients in 2025, or 33% of Thailand's NCD patients.
Mr. Pichitchai Jakpaisan, General Manager of Upjohn (Thailand) Limited, said, "We are focused on building an understanding of Upjohn as a leader in dealing with NCDs by building trust, demonstrating that we have high-quality products, and providing support through our medical expertise. There are already 15% of Thais who are NCD patients, or about 10.5 million patients. Unfortunately, 40 Thais die from NCDs every hour. This works out to 1,000 Thais every day, or 350,000 Thais who die every year from NCDs. These are sobering figures, but half of Thais dealing with NCDs can survive through effective prevention and treatment.1"
"We want to help the Thai people stay healthy for as long as they live. We have 20 brands available in Thailand, including therapies in the areas of cardiovascular disease, pain, urology, psychiatry, and other NCDs. We are focused on our mission to serve NCD products through three channels: government hospitals, private hospitals and retail. Through our strategies, we expect to cover more than 1.5 million patients in 2020 and 2 million patients in 2025, or 33% of Thailand NCD patients," noted Mr. Jakpaisan.
Dr. Sachin Rustagi, Research & Development Lead - Thailand & Indochina, Upjohn (Thailand) Limited, revealed that NCDs are a slow-moving disaster and the leading cause of death and disability, accounting for 71%, or 41 million, of all global deaths each year. Of the 41 million deaths, nearly 85% are in emerging markets and more than a third are premature. In Thailand, NCDs are the cause of death for over 75 percent of all Thai mortalities. The simple fact is that premature deaths are preventable. Doing nothing will cost about $7 trillion, while the cost of prevention is $170 billion worldwide.
In looking at the severity of the four major NCDs (coronary artery disease and cerebrovascular disease; cancer; chronic obstructive pulmonary disease; and diabetes), the risk factors include an unhealthy diet, tobacco use, harmful use of alcohol, physical inactivity, and air pollution.
"In this regard, the current standards, criteria, and surveillance approaches are insufficient for handling such concerns while decreasing the effects of NCDs in a comprehensive and efficient manner. It's important that we strengthen the coordination between the public and private sectors, and really focus on the key diseases. We need to have intersectional partnerships among the government, businesses, and professional and civil societies in order to effectively translate urgent policy priorities into action. We are focused on relieving the burden of NCDs with trusted, quality medicines for every patient, everywhere, with a goal of treating 225 million new patients worldwide by 2025, including in Thailand," said Dr. Rustagi.
To help patients living with uncontrolled risk factors that put them at risk of NCDs in the future, Upjohn launched the "Act today for tomorrow" program globally aiming to create urgency and underline the importance of better treating NCDs with Upjohn's portfolios.
"As a market leader in treating NCDs, we have a role to play in helping to improve the lives of patients tomorrow through better management today. Upjohn set up the Act today for tomorrow program with an aim to help the Thai people live healthy, longer lives in their life journey. This can be achieved in 3 important aspects. First, in terms of patients, we will raise awareness of preventive measures to maintain good health. For example, people need to do some exercise, get a health check-up, take good care of themselves and see a doctor if they get sick. Second, in terms of healthcare professionals, Upjohn will continue to provide an update on medical advancements and clinical studies in such events as symposiums and speaker programs. This can help equip healthcare professionals with the latest information on medicine. Finally, Upjohn is committed to providing quality medicines to patients. Meanwhile, we will ensure that there are enough supply of medicines and innovative products which are affordable and of high quality to every patient, everywhere," concluded Mr. Jakpaisan.
About Upjohn
With over 130 years of experience in improving patient lives, Upjohn seeks to leverage our portfolio, global experience, and expertise to become the trusted partner of choice for all stakeholders committed to improving patient health. We focus on relieving the burden of non-communicable diseases with trusted, quality medicines for every patient, everywhere, with the goal of treating 225 million new patients by 2025. Upjohn brings together 20 of the industry's most trusted brands with world-class medical, manufacturing, and commercial expertise in more than 120 countries. Upjohn's network of approximately 11,000 colleagues work together to be fast, focused and flexible to ensure that patients around the world access the healthcare they need.